Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
1.950
+0.030 (1.56%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Alector Market Cap
Alector has a market cap or net worth of $217.73 million as of September 25, 2026. Its market cap has decreased by -31.92% in one year.
Market Cap
217.73M
Enterprise Value
77.69M
1-Year Change
-31.92%
Ranking
Category
Stock Price
$1.95
ChartMarket Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $217.73M, a decrease of -82.31%. That is a compound annual growth rate of -20.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 217.73M | 27.87% |
| Dec 31, 2025 | 170.28M | -8.00% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 228.18M |
| Compugen | 225.44M |
| Cartesian Therapeutics | 224.19M |
| Entrada Therapeutics | 222.11M |
| Anavex Life Sciences | 220.62M |
| Protalix BioTherapeutics | 219.15M |
| Sol-Gel Technologies | 218.87M |
| Eledon Pharmaceuticals | 215.55M |